Endothelin receptor antagonism is protective in in vivo acute cyclosporine toxicity

178Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Endothelin (Et) has been implicated in cyclosporine A (CsA) nephrotoxicity. We have previously shown that CsA treatment in rats results in up-regulation of Et receptors specifically within the kidney. The role of Et in vivo CsA nephrotoxicity was therefore studied further with a new competitive antagonist, BQ-123, specific for EtA receptors (EtRA). Systemic administration of CsA in Munich-Wistar rats resulted in marked glomerular hypoperfusion and hypofiltration, with RPF in left and right kidneys falling by some 40% to 1.60 ± 0.25 and 1.73 ± 0.38 ml/min and GFR decreasing by some 20% to 0.61 ± 0.05 and 0.67 ± 0.11 ml/min, respectively. Selective infusion of EtRA into the left renal artery following systemic CsA treatment had no effect on this hemodynamic pattern (RPF 1.58 ± 0.29 and 1.92 ± 0.34 ml/min and GFR 0.60 ± 0.09 and 0.70 ± 0.08 ml/min in left and right kidneys, respectively, P = NS vs. CsA period). By contrast, intrarenal infusion of EtRA prior to systemic administration of CsA resulted in a strikingly different pattern of renal hemodynamics. Thus, EtRA pretreatment in the left kidney protected against glomerular dysfunction following CsA: RPF was maintained, 3.23 ± 0.28 ml/min versus 2.96 ± 0.31 (P = NS EtRA vs. EtRA + CsA), as was the GFR, 1.04 ± 0.16 ml/min versus 1.12 ± 0.09 (P = NS). However, the contralateral right kidneys of these rats, not pretreated with EtRA, showed no protective effect: RPF decreased from 3.15 ± 0.34 ml/min to 2.39 ± 0.19 and GFR from 1.04 ± 0.10 ml/min to 0.85 ± 0.07 (P < 0.05). Infusion of saline instead of EtRA was without protective effect, and EtRA itself did not alter systemic or renal hemodynamics. Systemic EtRA in a dose comparable to the intrarenal infusion given before CsA treatment was not protective: RPF fell from 3.36 ± 0.23 ml/min to 1.96 ± 0.33 (P < 0.005), and GFR decreased from 0.94 ± 0.06 ml/min to 0.67 ± 0.12 (P < 0.05). These studies support that local Et activation is pivotal in acute CsA nephrotoxicity. Local pretreatment with a specific EtA antagonist can largely prevent this CsA-induced glomerular hypofiltration and hypoperfusion.

Cite

CITATION STYLE

APA

Fogo, A., Hellings, S. E., Inagami, T., & Kon, V. (1992). Endothelin receptor antagonism is protective in in vivo acute cyclosporine toxicity. Kidney International, 42(3), 770–774. https://doi.org/10.1038/ki.1992.346

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free